openPR Logo
Press release

Alpha Emitter Market to Witness a CAGR of 23.44% during 2020 to 2026 Globally – Axiom MRC

07-22-2020 04:43 PM CET | Health & Medicine

Press release from: Axiom Market Research & Consulting

Alpha Emitter Market - Axiom MRC

Alpha Emitter Market - Axiom MRC

Wilmington, July 22, 2020: Axiom Market Research & Consulting™ published a report on global alpha emitter market which includes study on radionuclide type, medical application, end user across various countries of key regions across the globe. The global alpha emitter market was projected to grow at a CAGR of 23.44% for the forecast period 2020 to 2026. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the alpha emitter market.

Download Sample Report: https://www.axiommrc.com/requested_sample/1717-alpha-emitters-market-report

The report analyses the global alpha emitters market based on radionuclide type, medical application, end user and geography. Various radionuclide type studied are segmented into Actinium (Ac-225), Astatine (At-211), Bismuth (Bi -213), Bismuth (Bi-212), Lead (Pb-212), Radium (Ra-223) and Terbium (Tb-149). The medical application segment is categorized into prostate cancer, bone metastases, ovarian cancer, pancreatic cancer, endocrine tumors and others. Furthermore, the major end users considered in the study are hospitals, clinics and research laboratories. The global market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World.

The major players operating in the alpha emitter market include Actinium Pharmaceuticals (United States), Alpha Tau Medical (Israel), Bayer AG (Germany), Fusion Pharmaceuticals Inc. (Canada), IBA RadioPharma Solutions (Belgium), Orano Med (France), Plexus Corp. (Columbia), RadioMedix, Inc. (United States) and Telix Pharmaceuticals Ltd (Australia).

Browse for More Details: https://www.axiommrc.com/product/1717-alpha-emitters-market-report

Alpha Emitter Market Regional Trends
North America accounted for the largest market share in 2019 in terms of revenue followed by Europe. Owing to the fact that the increase in oncology and neurological chronic diseases is the major driving factor for the market growth in the NA region. Moreover, the Asia Pacific alpha emitters market is anticipated to grow at a fastest growth rate during the forecast period. Over the forecast period, the phenomenon anticipated to boost market expansion, is the rise in number of healthcare facilities and improvement in care provision.

Alpha Emitter Market Segmental Highlights:

• The Radium (Ra-223) segment dominated the global alpha emitters market in 2019
• Increase in awareness of the potential benefits of targeted alpha emitter and high number of patients with various types of cancers such as ovarian cancer, pancreatic cancer, lymphoma, and melanoma are likely to augment market growth
• The ovarian cancer segment dominated the global alpha emitters market, by medical application in 2019
• Use of targeted anticancer or alpha therapy (TAT) in the treatment of cancer and alpha particles to boost growth
• In addition, increasing use of targeted anticancer or alpha therapy (TAT) in the treatment of cancer and alpha particles has an advantage in targeted therapy because of their exceptionally high cell-killing ability. Ovarian cancer uses radio immunotherapy as locally injected adjuvant therapy

Research Objectives of Alpha Emitter Market Report:

• Analyzing the outlook of the market with the recent trends and Porter’s five forces analysis.
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the Alpha Emitter Market.
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments and strategies employed by the major market players

Our Other Related Reports:

Nuclear Medicine Market Report:
https://axiommrc.com/product/1689-nuclear-medicine-market-report

Biosimilars Market
https://axiommrc.com/product/hc1859-biosimilars-market-report

Contact Us:
Ganesh Sai
United States
3 Germay Dr. Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: sales@axiommrc.com

About Us:
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 700+ Market Research Projects, 2100+ Data Analytics Projects, 260+ Business Support Projects and has a 400+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

For more information, visit Axiom Market Research & Consulting™ at www.axiommrc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alpha Emitter Market to Witness a CAGR of 23.44% during 2020 to 2026 Globally – Axiom MRC here

News-ID: 2094973 • Views: 539

More Releases from Axiom Market Research & Consulting

Electrical SCADA Market New Innovation, Emerging Trends, Facts and Figures, Tech …
Electrical SCADAs stands for Supervisory Control and Data Acquisition. Electrical Supervisory Control and Data Acquisition is an industrial computer system that monitors and controls a process. Electrical SCADA market report sheds light on future opportunities, recent developments, competitive landscape and market opportunity analysis. It also offers a detailed look at some of the key elements of the overall market such as the drivers, restraints, threats, and opportunities present in the global
Meat Substitute Market: Global Demand Analysis & Opportunity Outlook 2027: Top p …
Wilmington, December, 2020: Axiom Market Research & Consulting™ added a report on global Meat Substitute which includes study on various market segments across various countries of key regions across the globe. Post COVID-19 pandemic impressive growth anticipated for this market. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Meat Substitute market. Get Sample PDF Copy @ https://bit.ly/34Km226 Major
Antibiotic Market Analysis, Share, Growth Trends, Global Opportunities, Industry …
Wilmington, December, 2020: Axiom Market Research & Consulting™ added a report on global Antibiotic which includes study on various market segments across various countries of key regions across the globe. Post COVID-19 pandemic impressive growth anticipated for this market. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Antibiotic market. Get Sample PDF Copy @ https://bit.ly/2K74fLh Major Players in Antibiotic Market Some of the key players
Charcoal Grill Market Size 2021-2027 by Industry Leading Players, Types and Appl …
What is Charcoal Grill ? A charcoal grill is the standard go-to grill. It is the classic, original and is mostly used for outdoor grilling. Charcoal grill barbecues are favoured over gas barbecues, as they are reasonably less expensive and easy to use. A gas barbecue involves electric supply and additional smoke to add the essential taste to food items. On the other hand, charcoal barbecues can be set up and

All 5 Releases


More Releases for Alpha

Alpha Xtra Boost Reviews - Does Alpha Xtra Boost Really Work?
Reduced testosterone among men is a growing concern. However, while many consider taking the aid of chemicals for this purpose, it is instead recommended to go for dietary formulas instead. Alpha Xtra Boost is one such natural supplement that provides users with a number of ways to boost their performance in bed. Get Alpha Xtra Boost Today >> https://rebrand.ly/o0aijnb What is Alpha Xtra Boost? This is a new dietary supplement that focuses
Geon Network Alpha App Reaches Major Milestone
December 11, 2018 – Gibraltar - Geon Network Limited (“GEON”, “Geon Network” or “Company”) today announced that the release of its Geon Network App (“GeonApp”) available at the Apple Store and Google Play has reached its first major milestone with over 10,000 user downloads. The initial alpha Geonapp was launched for Android OS on October 25, 2018 and for iOS on October 27, 2019. These are exciting times for the
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017, provides an overview of the Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline landscape. Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT),
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C …
"The Report Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic receptor or ADRA2C is an alpha-2 adrenergic receptor. It mediates the
Alpha Trains introduces zedas®asset
Europe’s largest lessor of rail vehicles counts on PC-Soft’s solution for asset and leasing management for vehicle fleets Following an international request for proposals, Alpha Trains has now put its trust in zedas®asset. They were particularly impressed with the powerful, consistent functions for maintenance management for rail vehicle fleets, the creation of leasing contracts and the integrated mobile functionality. Upon conclusion of this project, zedas®asset will be available as an information platform
Alpha Omega Wireless Exhibits at SXSW
Alpha Omega Wireless, Inc. will be exhibiting at the 2011 SXSW Interactive Festival. President Joe Wargo says, "We are extremenly excited o be able to participate in one of the most exciting events in the world. SXSW brings together music, video, and emerging technolgies all in one place. The one thing all entertainment and media have in common is the need for greater bandwidth. Wireless technologies play a key role in